Publikationen 2017 (Auswahl)

Blauschmidt S, Greither T, Lampe K, Köller S, Kaltwaßer P, Behre HM. Dipeptidyl Peptidase 4 serum activity and concentration are increased in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2017 Aug 11. [Epub ahead of print] PMID: 28799235


Greither TVorwerk F, Kappler M, Bache M, Taubert H, Kuhnt T, Hey J, Eckert AW. Salivary miR-93 and miR-200a as post-radiotherapy biomarkers in head and neck squamous cell carcinoma. Oncol Rep. 2017 Aug;38(2):1268-1275. Epub 2017 Jun 28. PMID: 28677748


Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M, Romero-Otero J, Martinez-Salamanca JI, Jones TH, Debruyne FMJ, Kurth KH, Hackett GI, Quinton R, Stroberg P, Reisman Y, Pescatori ES, Morales A, Bassas L, Cruz N, Cunningham GR, Wheaton OA; RHYME Investigators. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). J Sex Med. 2017 Aug 3. pii: S1743-6095(17)31339-5. 


Schill WB, Schuppe HC, Behre HMKöhn FM. In memoriam Carl Schirren. Andrologia. 2017 Aug;49(6). Epub 2017 Jul 13.  PMID: 28703310


Nieschlag E, Bouloux PG, Stegmann BJ, Shankar RR, Guan Y, Tzontcheva A, McCrary Sisk C, Behre HM. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism. Reprod Biol Endocrinol. 2017 Mar 7;15(1):17. PMID: 28270212

Publikationen 2016 (Auswahl)


Behre HM, Zitzmann M, Anderson RA, Handelsman DJ, Lestari SW, McLachlan RI, Meriggiola MC, Misro MM, Noe G, Wu FC, Festin MP, Habib NA, Vogelsong KM, Callahan MM, Linton KA, Colvard DS. Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men. J Clin Endocrinol Metab. 2016 Dec;101(12):4779-4788. Epub 2016 Oct 27. PMID: 27788052

Maggi M, Wu FC, Jones TH, Jackson G, Behre HM, Hackett G, Martin-Morales A, Balercia G, Dobs AS, Arver ST, Maggio M, Cunningham GR, Isidori AM, Quinton R, Wheaton OA, Siami FS, Rosen RC; RHYME Investigators. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME). Int J Clin Pract. 2016 Oct;70(10):843-852. PMID: 2777477

Keßler J, Rot S, Bache M, Kappler M, Würl P, Vordermark D, Taubert H, Greither T. miR-199a-5p regulates HIF-1α and OSGIN2 and its expression is correlated to soft-tissue sarcoma patients' outcome. Oncol Lett. 2016 Dec;12(6):5281-5288. Epub 2016 Oct 26. PMID: 28101243

 Debruyne FM, Behre HM, Roehrborn CG, Maggi M, Wu FC, Schröder FH, Jones TH, Porst H, Hackett G, Wheaton OA, Martin-Morales A, Meuleman E, Cunningham GR, Divan HA, Rosen RC; RHYME Investigators. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: Prostate health outcomes in the Registry of Hypogonadism in Men (RHYME). BJU Int. 2016 Jul 13. [Epub ahead of print]  PMID: 27409523

Simoni M, Santi D, Negri L, Hoffmann I, Muratori M, Baldi E, Cambi M, Marcou M, Greither T, Baraldi E, Tagliavini S, Carra D, Lombardo F, Gandini L, Pallotti F, Krausz C, Rastrelli G, Ferlin A, Menegazzo M, Pignatti E, Linari F, Marino M, Benaglia R, Levi-Setti PE, Behre HM. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study. Hum Reprod. 2016 Jun 20. [Epub ahead of print] PMID: 27329968

Brock G, Heiselman D, Maggi M, Kim SW, Rodríguez Vallejo JM, Behre HM, McGettigan J, Dowsett SA, Hayes RP, Knorr J, Ni X, Kinchen K. Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study. J Urol. 2016 Mar;195(3):699-705. PMID: 26498057

Publikationen 2015 (Auswahl)

Behre H.M., Howles C.M., Longobardi S; PERSIST Study Investigators. Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation. Reprod Biomed Online. 2015 Jun 15. pii: S1472-6483(15)00261-8. 26194884


Brock G., Heiselman D., Maggi M., Kim S.W., Rodríguez Vallejo J.M., Behre H.M., McGettigan J., Dowsett S.A., Hayes R.P., Knorr J., Ni X., Kinchen K. Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo-Controlled Study. J Urol. 2015 Oct 20. pii: S0022-5347(15)05023-5. 26498057


Zoch A., Mayerl S., Schulz A., Greither T., Frappart L., Rübsam J., Heuer H., Giovannini M., Morrison H. Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation. PLoS One. 2015 Aug 10;10(8):e0129151. 26258444


Kraus M., Greither T.Wenzel C., Bräuer-Hartmann D., Wabitsch M., Behre H.M. Inhibition of adipogenic differentiation of human SGBS preadipocytes by androgen-regulated microRNA miR-375. Mol Cell Endocrinol. 2015;414:177-85. 26219823


Bache M., Rot S., Keßler J., Güttler A., Wichmann H., Greither T., Wach S., Taubert H., Söling A., Bilkenroth U., Kappler M., Vordermark D. mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma. Oncol Rep. 2015 Jun;33(6):3155-61. 25963717


Wach S., Al-Janabi O., Weigelt K., Fischer K., Greither T.Marcou M., Theil G., Nolte E., Holzhausen H.J., Stöhr R., Huppert V., Hartmann A., Fornara P., Wullich B., Taubert H. The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer. Int J Cancer. 2015;137(6):1406-16. 25754273


Behre H.M., Bergmann M., Simoni M., Tüttelmann F. Primary Testicular Failure. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000-2015 Aug 30.   25905302